Clearline Capital LP

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1600136 NEW YORK, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,895,103

-$4,893,088 QoQ

Shares Held

11,383,961

-7.0% QoQ

Ownership

6.00%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

of 160 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Clearline Capital LP holds $23,992,695 across 4 Biotechnology names. HRTX ranks #3 (20.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADMA	Adma Biologics, Inc.	1,334,725	$11,171,648
2	VOR	Vor Biopharma Inc.	285,276	$5,251,931
3	HRTX	Heron Therapeutics, Inc. /De/ This page	11,383,961	$4,895,103
4	QURE	uniQure N.V.	58,055	$2,674,013

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,895,103	11,383,961	-7.0%	Shares	Sole	2026-08-14
2026-03-31	$9,788,191	12,235,239	0.0%	Shares	Sole	2026-05-15
2025-12-31	$15,905,810	12,235,239	+26.0%	Shares	Sole	2026-02-17
2025-12-31	$15,905,810	12,235,239	+26.0%	Shares	Sole	2026-02-17
2025-09-30	$12,237,784	9,712,527	—	Shares	Sole	2025-11-26
2025-09-30	$12,237,784	9,712,527	+1033.1%	Shares	Sole	2025-11-14
2025-06-30	$1,774,333	857,166	-19.1%	Shares	Sole	2025-08-14
2025-03-31	$2,331,804	1,059,911	-41.5%	Shares	Sole	2025-05-16
2024-12-31	$2,770,038	1,810,483	-18.7%	Shares	Sole	2025-02-14
2024-09-30	$4,430,758	2,226,512	+48.9%	Shares	Sole	2024-11-14
2024-06-30	$5,233,431	1,495,266	-46.1%	Shares	Sole	2024-08-15
2024-03-31	$7,690,085	2,776,204	-54.3%	Shares	Sole	2024-05-15
2023-12-31	$10,316,541	6,068,554	-1.3%	Shares	Sole	2024-02-14
2023-09-30	$6,334,337	6,149,842	+130.7%	Shares	Sole	2023-11-14
2023-06-30	$3,092,541	2,665,984	+27.6%	Shares	Sole	2023-08-15
2023-03-31	$3,154,830	2,089,292	+103.9%	Shares	Sole	2023-05-15
2022-12-31	$2,561,955	1,024,782	+2049.9%	Shares	Sole	2023-02-14
2020-03-31	$559,610	47,667	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.